Star Metro - Queue Ventures Announces TSX Conditional Approval

VANCOUVER, BC / ACCESS Newswire / April 9, 2026 / Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce that the Company has obtained conditional approval from the Toronto Stock Exchange (the "TSX") in respect of the listing of the common shares of Queue following the completion of its proposed statutory plan of arrangement and related transactions (the "Transaction") with Custom Health, Inc. ("Custom Health"), previously announced on May 30, 2025.

Completion of the Transaction is subject to a number of conditions, including those described in Queue's management information circular dated March 30, 2026 (the "Circular").

Further information concerning the Company, Custom Health and the Transaction are contained in the Circular, which is available for review under the Company's SEDAR+ profile at www.sedarplus.ca.

About Custom Health
Custom Health is a healthcare services company that offers an extensive suite of technology-enabled health services focused on patient outcomes management. Their integrated solution helps individuals maintain their health by addressing core medication management needs, including adherence to prescribed drug regimens and chronic disease management by tracking the real-time effectiveness of medications. Custom Health emphasizes individualized clinical, drug dispensing and administration capabilities, which are supported by proprietary internet-enabled technology. These services are tailored to meet the unique needs of each patient, driving the best possible outcomes.

About Queue Ventures Ltd.
Queue was formed under the Business Corporations Act (British Columbia)on October 29, 2021 and is an unlisted reporting issuer in each of British Columbia and Alberta. Queue has no commercial operations and no assets other than cash.

Further Information

For further information, please contact:
Queue Ventures Ltd.
515 - 701 West Georgia Street, P.O. Box 10068 Pacific Centre
Vancouver, British Columbia
V7Y 1C6, Canada
Contact: Mike Castanho
Email: [email protected]

This news release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.

Completion of the Transaction is subject to a number of conditions. There can be no assurance that the Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the Circular or other disclosure document to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon.

No stock exchange or regulatory authority has passed upon the merits of the Transaction or approved or disapproved of the contents of this news release.

All information contained in this news release with respect to Custom Health was supplied by Custom Health, and Queue and its directors and officers have relied on Custom Health for such information.

Cautionary Note Regarding Forward-Looking Information

This news release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Queue and Custom Health with respect to the Transaction. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding: expectations regarding the timing and completion of the Transaction and the listing of the common shares of Queue following the completion of the Transaction on the TSX.

This forward-looking information is subject to a number of assumptions, including that there will be no delays of the holding of the annual general and special meeting of Queue shareholders and the special meeting of Custom Health shareholders, the ability of the parties to receive, in a timely manner, the requisite shareholder, court, stock exchange, creditor and regulatory approvals and the ability of the parties to fully satisfy, in a timely manner, the other conditions to the closing of the Transaction. These dates may change for a number of reasons, including inability to secure requisite shareholder, court, stock exchange, creditor and regulatory approvals in the time assumed or the need for additional time to satisfy the other conditions to the completion of the Transaction. Accordingly, the reader should not place undue reliance on the forward-looking information contained in this news release concerning these times.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflect management of Queue and Custom Health's management, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Queue and Custom Health believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to consummate the Transaction; the ability of Custom Health to meet its obligations under its material agreements; the potential impact of the consummation of the Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction. This forward-looking information may be affected by risks and uncertainties in the business of Queue and Custom Health and market conditions as identified under the caption "Risk Factors" in the Circular and documents incorporated by reference therein.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward- looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Queue and Custom Health have attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Queue and Custom Health do not intend, and do not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

SOURCE: Queue Ventures Ltd.

View the original press release on ACCESS Newswire

T.Murray--SMC